Strategy of Neoadjuvant Therapy for Resectable/Borderline Resectable Pancreatic Cancer

被引：0
|
作者：
Hashimoto, D. [1 ]
Satoi, S. [1 ]
Yamamoto, T. [1 ]
Yamaki, S. [1 ]
Hirooka, S. [1 ]
Ishida, M. [1 ]
Ikeura, T. [1 ]
Sekimoto, M. [1 ]
机构：
[1] Kansai Med Univ, Hirataka, Japan
来源：
PANCREAS | 2021年 / 50卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1064 / 1064
页数：1
相关论文
共 50 条
  • [21] Pathologic tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer
    June S Peng
    Jane Wey
    Sricharan Chalikonda
    Daniela S Allende
    R Matthew Walsh
    Gareth Morris-Stiff
    Hepatobiliary&PancreaticDiseasesInternational, 2019, 18 (04) : 373 - 378
  • [22] Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
    Danko Mikulic
    Anna Mrzljak
    World Journal of Clinical Cases, 2021, 9 (20) : 5398 - 5407
  • [23] Toxicity associated with neoadjuvant therapy for borderline resectable pancreatic cancer (BRPC).
    Beg, M. S.
    Olowokure, O. O.
    Ali, S.
    Ahmad, S. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
    Mikulic, Danko
    Mrzljak, Anna
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (20) : 5398 - 5407
  • [25] Pathologic tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer
    Peng, June S.
    Wey, Jane
    Chalikonda, Sricharan
    Allende, Daniela S.
    Walsh, R. Matthew
    Morris-Stiff, Gareth
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 18 (04) : 373 - 378
  • [26] Pathological tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer
    Stefan Heinrich
    Hepatobiliary&PancreaticDiseasesInternational, 2019, 18 (04) : 305 - 306
  • [27] Pathological tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer
    Heinrich, Stefan
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 18 (04) : 305 - 306
  • [28] Neoadjuvant Chemoradiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma
    Shafi, S.
    Kaubisch, A.
    PANCREAS, 2015, 44 (08) : 1413 - 1413
  • [29] Early outcomes following neoadjuvant therapy for borderline resectable pancreatic cancer
    Goody, R.
    Arunsingh, M.
    Murray, L.
    Adair, R.
    Albazaz, R.
    Anthoney, A.
    Beckett, C.
    Cairns, A.
    Collinson, F.
    Guthrie, A.
    Kenyon, A.
    Macutkiewicz, C.
    Sanni, L.
    Sheridan, M.
    Smith, A.
    Trainor, P.
    Radhakrishna, G.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S776 - S777
  • [30] Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons
    Nichols, Romaine Charles
    Rutenberg, Michael
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 11 (07): : 303 - 307
12345